Live Breaking News & Updates on David Nicolau

Stay updated with breaking news from David nicolau. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

IDWeek 2023: Shionogi and Qpex Biopharma, Inc. Continue Longstanding Commitment to Addressing Unmet Needs in Infectious Disease

FLORHAM PARK, N.J., September 07, 2023 Shionogi Inc., the United States subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), announced the upcoming presentation of new data at IDWeek 2023 (October 11-15, 2023) on its investigational oral antiviral for COVID-19, ensitrelvir (Generic name: ensitrelvir fumaric acid, Code No.: S-217622, hereafter "ensitrelvir"), and Fetroja® (cefiderocol), an antibiotic marketed under the brand name Fetcro ....

United States , David Nicolau , Isao Teshirogi , Olga Lomovskaya , Shionogi Co Ltd , Head Office , Antimicrobial Surveillance Program , Qpex Biopharma Inc , Global Antibiotic Research , Surveillance Program , Clinton Health Access Initiative , Development Partnership , Shionogi Inc , Chief Executive Officer , Qpex Biopharma , Senior Vice President , Clinical Microbiology , Pipeline Part , Japanese Clinical Practice , Post Marketing Surveillance , Interim Analysis , Taste Disorder , Smell Disorder , Combined Results , Controlled Trials , Population Pharmacokinetic Analysis ,